Cue Biopharma (CUE) awards 109,178-share RSU and PSU package to legal chief
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Ray Sumita reported acquisition or exercise transactions in this Form 4 filing.
Cue Biopharma, Inc. granted Chief Legal Compliance Officer and Corporate Secretary Sumita Ray a total of 109,178 shares tied to equity awards on July 9, 2026. The awards comprise 54,589 restricted stock units (RSUs) vesting in equal quarterly installments over 48 months and 54,589 performance stock units (PSUs) that vest in three tranches only if stock-price targets of $33.00, $38.50 and $44.00 are each maintained for five consecutive trading days by 24 months from grant, otherwise the PSUs are forfeited.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Ray Sumita
Role
Chief Legal Compliance Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 54,589 | $0.00 | -- |
| Grant/Award | Common Stock | 54,589 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 54,589 shares (Direct)
Footnotes (1)
- Represents that grant of restricted stock units ("RSUs"). The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date. Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.
Key Figures
RSU grant size: 54,589 shares
PSU grant size: 54,589 shares
Shares owned after transaction: 109,178 shares
+5 more
8 metrics
RSU grant size
54,589 shares
Restricted stock units granted to Sumita Ray on July 9, 2026
PSU grant size
54,589 shares
Performance stock units granted to Sumita Ray on July 9, 2026
Shares owned after transaction
109,178 shares
Direct ownership by Sumita Ray following the grants
RSU vesting period
48 months
RSUs vest in equal quarterly installments from the grant date
First PSU stock-price hurdle
$33.00
Closing price per share required for first PSU tranche vesting
Second PSU stock-price hurdle
$38.50
Closing price per share required for second PSU tranche vesting
Third PSU stock-price hurdle
$44.00
Closing price per share required for third PSU tranche vesting
PSU performance window
24 months
Period from grant during which stock-price targets must be met before forfeiture
Key Terms
restricted stock units ("RSUs"), performance stock units ("PSUs"), closing price per share, trading days, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents that grant of restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
performance stock units ("PSUs") financial
"Represents the grant of performance stock units ("PSUs")."
trading days financial
"in each case for a period of five consecutive trading days."
Trading days are the specific days when a stock exchange is open and buying and selling of securities can occur, excluding weekends and exchange-declared holidays. Investors use trading days to measure performance, calculate settlement deadlines and time-sensitive events—think of them as the business hours calendar for markets, where returns, volumes and deadlines are counted only on days the market is operating.
forfeited and cancelled without consideration financial
"the PSUs shall automatically be forfeited and cancelled without consideration."
FAQ
What insider transaction did Cue Biopharma (CUE) report for Sumita Ray?
Cue Biopharma reported that Sumita Ray, its Chief Legal Compliance Officer, received equity awards totaling 109,178 shares. These include RSUs vesting quarterly over 48 months and PSUs vesting only upon achieving specified stock-price hurdles within 24 months.
How many RSUs did Sumita Ray receive from Cue Biopharma (CUE)?
Sumita Ray received a grant of 54,589 restricted stock units (RSUs). These RSUs vest in equal quarterly installments over a 48‑month period from the grant date, conditioned on her continued service with Cue Biopharma.
What performance conditions apply to Sumita Ray’s PSUs at Cue Biopharma (CUE)?
The 54,589 PSUs are split into three tranches that may vest if Cue Biopharma’s stock closes at $33.00, $38.50, and $44.00 for five consecutive trading days. If these targets are not met within 24 months, the PSUs are forfeited.
Did Sumita Ray pay any purchase price for the Cue Biopharma (CUE) awards?
The reported RSU and PSU grants to Sumita Ray list a transaction price per share of $0.00. These appear as compensation-related equity awards rather than open‑market purchases of Cue Biopharma stock.
Over what timeframe can Cue Biopharma (CUE) PSUs granted to Sumita Ray vest?
The PSUs can vest if the stock-price targets are achieved within 24 months from the grant date. If the closing-price conditions are not met in that period, all unvested PSUs are automatically forfeited without consideration.